Skip to main content
Evotec SE logo

Evotec SE — Investor Relations & Filings

Ticker · EVT ISIN · DE0005664809 LEI · 529900F9KI6OYITO9B12 F Professional, scientific and technical activities
Open in API
Filings indexed 1,773 across all filing types
Latest filing 2021-11-11 Declaration of Voting R…
Country DE Germany
Listing F EVT

About Evotec SE

https://www.evotec.com/en

Evotec SE is a life science company focused on drug discovery and development in partnership with pharmaceutical and biotechnology firms. The company operates an integrated research and development value chain, utilizing proprietary technology platforms that incorporate AI-driven innovation and induced pluripotent stem cells (iPSC). Its expertise spans a wide range of therapeutic modalities, from small molecules to biotherapeutics. Through its Just – Evotec Biologics division, the company offers end-to-end solutions for the design, development, and manufacturing of biologic therapies, aiming to enhance their accessibility and affordability. Evotec employs flexible partnering models to accelerate the delivery of new treatments to patients with high efficiency and quality.

Recent filings

Filing Released Lang Actions
Declaration of Voting Results & Voting Rights Announcements 2021
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'Voting Rights Announcements' and explicitly states 'Notification of Major Holdings' regarding BlackRock, Inc.'s voting rights in Evotec SE. It details the acquisition/disposal of shares with voting rights, crossing a threshold on 05 Nov 2021, and provides a breakdown of total positions (shares and instruments). This content directly corresponds to notifications required when major shareholders change their stake, which falls under the category of Major Shareholding Notification (MRQ) or, given the context of voting rights disclosure under German law (WpHG), it is a specific type of regulatory disclosure concerning ownership changes. Since 'Major Shareholding Notification' (MRQ) is provided as a specific category for 'Notification of changes in significant share ownership levels (crossing thresholds)', this is the most appropriate classification. The document is a formal regulatory filing detailing ownership changes, not a general regulatory announcement (RNS) or a proxy solicitation (PSI).
2021-11-11 English
Evotec SE reports results for the first nine months 2021 and provides corporate update
Earnings Release Classification · 100% confidence The document explicitly states it reports 'results for the first nine months 2021' and provides detailed financial highlights, including revenues, EBITDA, and segment performance for the 9M 2021 period compared to 9M 2020. This content aligns perfectly with the definition of a comprehensive financial report for a period shorter than a year. Although it is distributed via a news service (DGAP), the core content is the financial report itself, not just an announcement of its publication. Therefore, it should be classified as an Interim / Quarterly Report (IR). 9M 2021
2021-11-11 English
Präsentation Q3 2021
Investor Presentation Classification · 100% confidence The document is a slide deck presentation titled 'Rapid Progress on the data-driven Autobahn to Cures' and 'Welcome to 9M 2021'. It contains financial highlights, condensed income statements for 9M 2021 and Q3 2021, segment information, and strategic updates. As it is a detailed presentation for investors focusing on financials, strategy, and market position, it is classified as an Investor Presentation. 9M 2021
2021-11-11 English
Evotec reaches programme designations in neuroscience collaboration with Bristol Myers Squibb
Regulatory Filings Classification · 95% confidence The document is a press release format, indicated by the 'News Details' header, date/time stamp, and the use of DGAP (a service for corporate news dissemination). The content announces a specific business development: Evotec reaching programme designations in a collaboration with Bristol Myers Squibb, triggering payments. This is not a comprehensive financial report (like 10-K or IR), nor is it a formal regulatory filing like a Director's Dealing or Major Shareholding Notification. It is a corporate announcement regarding operational progress and financial milestones within a partnership. Since it is a general corporate news item that doesn't fit the specific categories like ER (Earnings Release), CAP (Financing Update), or LTR (Legal Proceedings), the most appropriate fallback category is Regulatory Filings (RNS), which often serves as the catch-all for non-standard corporate news disseminated via official channels like DGAP.
2021-11-10 English
Evotec SE announces closing of public offering
Share Issue/Capital Change Classification · 99% confidence The document is a press release from Evotec SE, dated November 9, 2021, announcing the 'closing of public offering' of American Depositary Shares (ADSs). It details the number of shares, the offering price, the exercise of the underwriters' option, and the expected gross proceeds ($500 million). This content directly relates to fundraising, financing activities, and capital structure changes (issuance of new securities via an offering). This aligns perfectly with the definition for Capital/Financing Update (CAP). It is not a full annual report (10-K), an earnings release (ER), or a management discussion (MDA).
2021-11-09 English
Correction of a release from 05/11/2021, 15:48 CET/CEST - Evotec SE: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'Total Voting Rights Announcement' and explicitly mentions the publication of the 'total number of voting rights' (175,110,695). It references German securities law (WpHG) and is distributed via DGAP, a service for regulatory announcements. This content directly relates to changes in the capital structure concerning voting rights, which aligns best with the 'Share Issue/Capital Change' (SHA) definition, as a capital increase is mentioned, or potentially 'Regulatory Filings' (RNS) if it were a general announcement. However, since it specifically details a capital measure (Conditional capital increase) and the resulting total voting rights, SHA is the most precise fit among the specific categories. It is not a general report announcement (RPA) because it contains the actual data, not just a notice about a report.
2021-11-08 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.